
AMLX
Amylyx Pharmaceuticals
$19.49
+$1.08 (+5.87%)Jul 27, 2026
Key metrics
The numbers that frame AMLX today
- Market cap
- $2.17B
- P/E (TTM)
- -14.4
- EV / FCF
- -16.1
- ROIC
- -158.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $7.48
- 52wk High
- $19.60
Growth
Revenue and earnings trend for AMLX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AMLX
Is Amylyx Pharmaceuticals a good buy?
Hold. Amylyx Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Amylyx Pharmaceuticals is selling at a high price.
What is the market capitalization of AMLX?
Amylyx Pharmaceuticals's market capitalization is $2.17B.
What is the P/E ratio for AMLX stock?
Amylyx Pharmaceuticals's current P/E ratio is -14.4.
What is the 52-week high for AMLX stock?
The 52-week high for Amylyx Pharmaceuticals is $19.60. The current close of $19.49 is 0.6% below that high.
What is the 52-week low for AMLX stock?
The 52-week low for Amylyx Pharmaceuticals is $7.48. The current close of $19.49 is 160.6% above that low.
Does AMLX stock pay dividends?
Amylyx Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AMLX?
Amylyx Pharmaceuticals's Debt / Equity ratio is 0.02.